Marc Therrien

Title: The Innovative Contributions of Marc Therrien

Introduction

Marc Therrien is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of biosensors, particularly in the detection of RAF/KSR family kinase dimerization. His work has implications for understanding cellular processes and developing potential therapeutic interventions.

Latest Patents

Marc Therrien holds a patent for a biosensor designed to detect the dimerization of RAF and/or KSR polypeptides. This innovative biosensor comprises fusion proteins that include RAF and/or KSR proteins fused to bioluminescent or fluorescent proteins. The patent outlines methods for using these biosensors to measure dimerization through resonance energy transfer techniques such as BRET or FRET. This technology can be utilized to screen for inhibitors of dimerization, which is crucial for advancing cancer research and treatment.

Career Highlights

Throughout his career, Marc Therrien has worked with esteemed institutions such as Mount Sinai Hospital Corporation and Université de Montreal. His experience in these organizations has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in the field of biosensors and kinase dimerization.

Collaborations

Marc has collaborated with notable colleagues, including Hugo Lavoie and Malha Sahmi. Their combined expertise has furthered the research and development of innovative biosensor technologies.

Conclusion

Marc Therrien's contributions to the field of biosensors and kinase dimerization exemplify the impact of innovative thinking in scientific research. His patent and collaborative efforts highlight the importance of advancing technology for medical applications.